News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features The Next Blaze: Pandemic Burnout Among Health Professionals Michael O'Riordan June 05, 2020
News Features Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes Michael O'Riordan May 12, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020